These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 7895657)
1. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Szalkowski D; White-Carrington S; Berger J; Zhang B Endocrinology; 1995 Apr; 136(4):1474-81. PubMed ID: 7895657 [TBL] [Abstract][Full Text] [Related]
2. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes. Shimaya A; Kurosaki E; Shioduka K; Nakano R; Shibasaki M; Shikama H Horm Metab Res; 1998 Sep; 30(9):543-8. PubMed ID: 9808320 [TBL] [Abstract][Full Text] [Related]
3. The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Sandouk T; Reda D; Hofmann C Endocrinology; 1993 Jul; 133(1):352-9. PubMed ID: 8319581 [TBL] [Abstract][Full Text] [Related]
4. Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Ohsumi J; Sakakibara S; Yamaguchi J; Miyadai K; Yoshioka S; Fujiwara T; Horikoshi H; Serizawa N Endocrinology; 1994 Nov; 135(5):2279-82. PubMed ID: 7956951 [TBL] [Abstract][Full Text] [Related]
5. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes. Tafuri SR Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Ruan H; Hacohen N; Golub TR; Van Parijs L; Lodish HF Diabetes; 2002 May; 51(5):1319-36. PubMed ID: 11978627 [TBL] [Abstract][Full Text] [Related]
7. Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent. Kletzien RF; Foellmi LA; Harris PK; Wyse BM; Clarke SD Mol Pharmacol; 1992 Oct; 42(4):558-62. PubMed ID: 1435736 [TBL] [Abstract][Full Text] [Related]
8. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470 [TBL] [Abstract][Full Text] [Related]
9. Regulation of CCAAT/enhancer binding protein alpha (C/EBP alpha) gene expression by thiazolidinediones in 3T3-L1 adipocytes. Hemati N; Erickson RL; Ross SE; Liu R; MacDougald OA Biochem Biophys Res Commun; 1998 Mar; 244(1):20-5. PubMed ID: 9514873 [TBL] [Abstract][Full Text] [Related]
10. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. Wu Z; Xie Y; Morrison RF; Bucher NL; Farmer SR J Clin Invest; 1998 Jan; 101(1):22-32. PubMed ID: 9421462 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Kletzien RF; Clarke SD; Ulrich RG Mol Pharmacol; 1992 Feb; 41(2):393-8. PubMed ID: 1538716 [TBL] [Abstract][Full Text] [Related]
13. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. Liu F; Kim J; Li Y; Liu X; Li J; Chen X J Nutr; 2001 Sep; 131(9):2242-7. PubMed ID: 11533261 [TBL] [Abstract][Full Text] [Related]
14. Effects of cell-permeable ceramides and tumor necrosis factor-alpha on insulin signaling and glucose uptake in 3T3-L1 adipocytes. Wang CN; O'Brien L; Brindley DN Diabetes; 1998 Jan; 47(1):24-31. PubMed ID: 9421370 [TBL] [Abstract][Full Text] [Related]
16. Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene. Harris PK; Kletzien RF Mol Pharmacol; 1994 Mar; 45(3):439-45. PubMed ID: 8145730 [TBL] [Abstract][Full Text] [Related]
17. Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake. Hamm JK; el Jack AK; Pilch PF; Farmer SR Ann N Y Acad Sci; 1999 Nov; 892():134-45. PubMed ID: 10842659 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Stephens JM; Pekala PH J Biol Chem; 1991 Nov; 266(32):21839-45. PubMed ID: 1939208 [TBL] [Abstract][Full Text] [Related]
19. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes. Rosenbaum SE; Greenberg AS Mol Endocrinol; 1998 Aug; 12(8):1150-60. PubMed ID: 9717841 [TBL] [Abstract][Full Text] [Related]
20. The two tumor necrosis factor receptors mediate opposite effects on differentiation and glucose metabolism in human adipocytes in primary culture. Hube F; Hauner H Endocrinology; 2000 Jul; 141(7):2582-8. PubMed ID: 10875261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]